Jefferies Has Wall Street’s Highest Target on Eli Lilly (LLY). Why?
We just published a list of the Morgan Stanley’s Vintage Values 2027: 10 Stocks Analysts See Climbing Further and Eli Lilly (NYSE:LLY) ranked 10th on this...
Read more
Historical closes from the market data provider. Adjusted for splits; corporate actions can affect comparability across periods.
Metrics supplied by the company data provider. Trailing-twelve-month figures update when the provider refreshes its dataset.
Fiscal years 2022, 2023, 2024, 2025. All figures in USD. Values are as reported by the company.
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total revenue | $28.54B | $34.12B | $45.04B | $65.18B |
| Gross profit | $21.91B | $27.04B | $36.63B | $54.13B |
| Operating income | $8.28B | $10.33B | $17.04B | $29.70B |
| Net income | $6.24B | $5.24B | $10.59B | $20.64B |
| Diluted EPS | 6.57 | 5.80 | 11.71 | 22.95 |
| Total assets | $49.49B | $64.01B | $78.72B | $112.48B |
| Shareholders' equity | $10.65B | $10.77B | $14.27B | $26.54B |
| Operating cash flow | $7.59B | $4.24B | $8.82B | $16.81B |
| Free cash flow | $4.60B | $-3.15B | $414.00M | $5.96B |
Annual statements sourced from the market data provider. Companies with different fiscal year ends are not directly comparable on a calendar basis.
| Ex-date | Amount per share |
|---|---|
| 13 Nov 2026 | $1.7300 |
| 14 Aug 2026 | $1.7300 |
| 15 May 2026 | $1.7300 |
| 13 Feb 2026 | $1.7300 |
| 14 Nov 2025 | $1.5000 |
| 15 Aug 2025 | $1.5000 |
| 16 May 2025 | $1.5000 |
| 14 Feb 2025 | $1.5000 |
| 15 Nov 2024 | $1.3000 |
| 15 Aug 2024 | $1.3000 |
| 15 May 2024 | $1.3000 |
| 14 Feb 2024 | $1.3000 |
| 14 Nov 2023 | $1.1300 |
| 14 Aug 2023 | $1.1300 |
| 12 May 2023 | $1.1300 |
| 14 Feb 2023 | $1.1300 |
| 14 Nov 2022 | $0.9800 |
| 12 Aug 2022 | $0.9800 |
| 13 May 2022 | $0.9800 |
| 14 Feb 2022 | $0.9800 |
Amounts are as declared and are not adjusted for withholding tax. Dividend policy can change at any time.
| Period | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| 2026-09-30 · Q3 2026 | 6.32 | 7.48 | +18.32% |
| 2026-06-30 · Q2 2026 | 6.07 | 8.38 | +38.14% |
| 2026-03-31 · Q1 2026 | 6.73 | 8.55 | +27.04% |
| 2025-12-31 · Q4 2025 | 6.74 | 7.54 | +11.92% |
Estimates are consensus figures collected by the data provider. Reported values can be restated after publication.
We just published a list of the Morgan Stanley’s Vintage Values 2027: 10 Stocks Analysts See Climbing Further and Eli Lilly (NYSE:LLY) ranked 10th on this...
Read more
Sanofi and Regeneron both scored in the rare disease space while Lilly's dealmaking streak continued.
Read more
Many investors are moving money out of AI and technology and into defensive sectors.
Read more
Blue chip stocks dominate the list of hedge funds' most popular equity investments.
Read more
Analyst rates Novo Nordisk A/S a Buy, calling its 10â11x forward P/E inexpensive; stronger-than-expected 2027 guidance could restore momentum.
Read more
Eli Lilly and Company (NYSE:LLY) rounds out our list of the Top 10 Stocks to Buy According to Billionaire Ken Fisher at number 10. Ken Fisher has spent mor...
Read more
One molecule turned a diversified drugmaker into a trillion-dollar giant, yet recent buyers have watched shares swing hard even as revenue surged. Does Lil...
Read more
Pfizer's $2.6 billion Starna deal adds three investigational CAR-T programs, strengthening its push into next-generation autoimmune treatments.
Read more
General Medicine, a healthcare store founded by the team behind PillPack and Amazon Pharmacy, today announced that its GLP-1 weight management care is avai...
Read more
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q3 2026 inv...
Read moreHeadlines and summaries are supplied by third-party news providers. Links open the original publisher. Inclusion does not imply endorsement.
Add the app to your home screen for faster access to market data.
Use Google Chrome on your Android phone or tablet. Other Chromium browsers such as Edge or Samsung Internet work too.
Tap the three-dot menu in the top-right corner of the browser.
Select Install app or Add to Home screen from the menu.
Tap Install in the prompt. The Expert Options View icon appears on your home screen and app drawer.
On iPhone or iPad, installation only works in Safari. Open this page in Safari rather than Chrome or Firefox.
Tap the Share icon in the toolbar at the bottom of the screen.
Swipe down the share sheet and tap Add to Home Screen.
Confirm with Add in the top-right corner. The app icon is added to your home screen and opens full screen.
The app is free, takes no extra storage beyond a small cache, and works on Android and iOS. No app store account is needed.